Study shows potential for new radiopharmaceutical cancer treatment
by Elizabeth Chapin,University of KentuckyGastrin- releasing peptide receptor (GRPR) immunoreactivity in uterine cervix cancer. Hematoxylin and eosin (H&E) staining of uterine cervix cancer
Updated on: February 20,2024
16

Study shows potential for new radiopharmaceutical cancer treatment
by Elizabeth Chapin,University of KentuckyGastrin- releasing peptide receptor (GRPR) immunoreactivity in uterine cervix cancer. Hematoxylin and eosin (H&E) staining of uterine cervix cancer
Updated on:February 20,2024
16
